Pharmarise Holdings Corp. said its normalized net income for the fiscal second quarter ended Nov. 30, 2014, amounted to ¥20.31 per share, a decrease of 11.2% from ¥22.86 per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥186.5 million, a gain of 8.1% from ¥172.5 million in the year-earlier period.
The normalized profit margin increased to 1.9% from 1.9% in the year-earlier period.
Total revenue increased 6.6% on an annual basis to ¥9.87 billion from ¥9.25 billion, and total operating expenses grew 6.6% on an annual basis to ¥9.49 billion from ¥8.90 billion.
Reported net income grew year over year to ¥107.9 million, or ¥11.75 per share, from ¥52.7 million, or ¥6.93 per share.
As of Jan. 14, US$1 was equivalent to ¥116.84.
